SCHEMBL28527166

SCHEMBL28527166

CCOC(=O)[C@H]1CC[C@@H](c2ccc(F)c(Cl)c2)N1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.49
KCNH2 Q12809 8/20 0.41
SCN3A Q9NY46 6/20 0.41
PRKAG1 P54619 1/20 0.41
PRKAA1 Q13131 1/20 0.41
PRKAB1 Q9Y478 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.40
KDM4E B2RXH2 1/20 0.40
POLB P06746 1/20 0.40
TSHR P16473 1/20 0.40
SCN1A P35498 1/20 0.39
SCN4A P35499 1/20 0.39
SCN7A Q01118 1/20 0.39
SCN5A Q14524 1/20 0.39
SCN9A Q15858 1/20 0.39
SCN2A Q99250 1/20 0.39
SCN8A Q9UQD0 1/20 0.39
SCN10A Q9Y5Y9 1/20 0.39
ALDH1A1 P00352 1/20 0.39
KMT2A Q03164 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2348802 0.89 ALDH1A1 (0.46) KCNH2SCN3AKDM4ETSHRSCN1A
SCHEMBL15832346 0.89 TSHR (0.46) SMN1; SMN2KDM4ETSHRALDH1A1KMT2A
SCHEMBL2346176 0.85 MEN1 (0.47) KCNH2SCN3ASMN1; SMN2POLBTSHR
SCHEMBL28534238 0.83 MEN1 (0.42) KCNH2SMN1; SMN2KDM4EPOLBTSHR
SCHEMBL21094085 0.83 KCNH2 (0.44) KCNH2SMN1; SMN2KDM4ETSHRALDH1A1
SCHEMBL4637526 0.82 KCNH2 (0.56) KCNH2SCN3ASCN1ASCN4ASCN7A
SCHEMBL2350627 0.82 KCNH2 (0.56) KCNH2SCN3ASCN1ASCN4ASCN7A
SCHEMBL3585032 0.82 KCNH2 (0.56) KCNH2SCN3ASCN1ASCN4ASCN7A
SCHEMBL3585037 0.82 KCNH2 (0.56) KCNH2SCN3ASCN1ASCN4ASCN7A
SCHEMBL4637528 0.82 KCNH2 (0.56) KCNH2SCN3ASCN1ASCN4ASCN7A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109476639-B Pyrrolidine derivatives 橘生药品工业股份有限公司 2021-02-26 CN disclosed